David Hirsh
Vorsitzender bei New York Structural Biology Center, Inc.
Profil
David I.
Hirsh currently works at New York Structural Biology Center, Inc., as Chairman, Cellphire, Inc., as Director, Visum Pharma, Inc., as Director, Warburg Pincus LLC, as Advisory Board, The Trustees of Columbia University in The City of New York, as Executive Vice President-Research from 2003, and Accelerator Services Corp, as Advisory Board.
Dr. Hirsh also formerly worked at ZymoGenetics, Inc., as Director from 2000 to 2010, Synergen, Inc., as Executive Vice President-Research from 1984 to 1990, and The University of Colorado, as Professor from 1971 to 1985.
Dr. Hirsh received his undergraduate degree from The Reed Institute and doctorate degree from The Rockefeller University.
Aktive Positionen von David Hirsh
Unternehmen | Position | Beginn |
---|---|---|
The Trustees of Columbia University in The City of New York | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2003 |
New York Structural Biology Center, Inc.
New York Structural Biology Center, Inc. BiotechnologyHealth Technology New York Structural Biology Center, Inc. provides resources in structural biology to its members and outside users. Its services include advanced instrumentation and expertise for NMR, X-ray crystallography and electron microscopy. The company was founded in 1999 and is headquartered in New York, NY. | Vorsitzender | - |
Cellphire, Inc.
Cellphire, Inc. BiotechnologyHealth Technology Cellphire, Inc. develops proprietary method for the long-term stabilization of platelets in the dry state. It focuses on developing stabilized cellular materials for advanced technologies in the therapeutic and diagnostic markets through its proprietary cell stabilization technology. The company was founded by Richard O. Cliff in 2005 and is headquartered in Rockville, MD. | Direktor/Vorstandsmitglied | - |
Warburg Pincus LLC
Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Berater | - |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Berater | - |
Visum Pharma, Inc.
Visum Pharma, Inc. Pharmaceuticals: MajorHealth Technology Visum Pharma, Inc. provides therapeutics for neurodegenerative diseases. The company is based in Stamford, CT. The CEO of the company is William J. Gedale. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von David Hirsh
Unternehmen | Position | Ende |
---|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | 08.10.2010 |
Synergen, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1990 |
The University of Colorado | Corporate Officer/Principal | 01.01.1985 |
Ausbildung von David Hirsh
The Reed Institute | Undergraduate Degree |
The Rockefeller University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 7 |
---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Synergen, Inc. | Utilities |
New York Structural Biology Center, Inc.
New York Structural Biology Center, Inc. BiotechnologyHealth Technology New York Structural Biology Center, Inc. provides resources in structural biology to its members and outside users. Its services include advanced instrumentation and expertise for NMR, X-ray crystallography and electron microscopy. The company was founded in 1999 and is headquartered in New York, NY. | Health Technology |
Cellphire, Inc.
Cellphire, Inc. BiotechnologyHealth Technology Cellphire, Inc. develops proprietary method for the long-term stabilization of platelets in the dry state. It focuses on developing stabilized cellular materials for advanced technologies in the therapeutic and diagnostic markets through its proprietary cell stabilization technology. The company was founded by Richard O. Cliff in 2005 and is headquartered in Rockville, MD. | Health Technology |
Warburg Pincus LLC
Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Finance |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Visum Pharma, Inc.
Visum Pharma, Inc. Pharmaceuticals: MajorHealth Technology Visum Pharma, Inc. provides therapeutics for neurodegenerative diseases. The company is based in Stamford, CT. The CEO of the company is William J. Gedale. | Health Technology |